(VUKE) Vanguard FTSE 100 - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B810Q511 • UK Large-Cap Equity
VUKE: ETF, Index, Fund, Equity, UK
Vanguard FTSE 100 UCITS GBP Inc (XETRA:VUKE) is a Germany-domiciled exchange-traded fund designed to track the performance of the Morningstar UK All Cap TME NR GBP Index. The fund provides exposure to large-cap equities in the UK market, replicating the returns of its underlying index through physical possession of securities. It is structured as a UCITS-compliant ETF, making it accessible to investors across Europe. The ETF is listed on XETRA, offering liquidity and accessibility to European investors seeking UK market exposure.
From a technical perspective, the ETF shows a bullish crossover in short-term momentum, with its 20-day SMA (42.32) rising above the 50-day SMA (43.96). The 200-day SMA (42.72) remains below the current price, indicating a neutral to slightly bullish long-term trend. The Average True Range (ATR) of 0.78 reflects moderate price volatility. The funds average daily trading volume over the past 20 days is 6,342 shares, with a last price of 43.10. The funds assets under management (AUM) stand at €4,930.74 million, underscoring its status as a widely held and liquid investment vehicle.
Over the next three months, VUKE is expected to maintain its correlation with the UK large-cap equity market, with potential upside driven by stabilizing macroeconomic conditions. The 20-day SMA crossing above the 50-day SMA suggests short-term bullish momentum, while the 200-day SMA near current price levels indicates a potential support zone. The ATR of 0.78 signals manageable volatility, supporting a stable trading environment. Fundamentally, the ETFs large AUM and tracking error of 0.20% (as of latest data) suggest continued investor confidence and tight tracking of its underlying index.
Additional Sources for VUKE ETF
VUKE ETF Overview
| Market Cap in USD | 5,535m |
| Category | UK Large-Cap Equity |
| TER | 0.10% |
| IPO / Inception | 2012-05-22 |
VUKE ETF Ratings
| Growth Rating | 77.7 |
| Fundamental | - |
| Dividend Rating | 65.1 |
| Rel. Strength | -14.2 |
| Analysts | - |
| Fair Price Momentum | 44.98 EUR |
| Fair Price DCF | - |
VUKE Dividends
| Dividend Yield 12m | 4.03% |
| Yield on Cost 5y | 7.00% |
| Annual Growth 5y | 10.65% |
| Payout Consistency | 82.8% |
VUKE Growth Ratios
| Growth Correlation 3m | -76.6% |
| Growth Correlation 12m | 74% |
| Growth Correlation 5y | 96.6% |
| CAGR 5y | 11.96% |
| CAGR/Max DD 5y | 0.71 |
| Sharpe Ratio 12m | 1.52 |
| Alpha | -0.15 |
| Beta | 0.506 |
| Volatility | 11.34% |
| Current Volume | 20k |
| Average Volume 20d | 7.1k |
As of May 12, 2025, the stock is trading at EUR 44.16 with a total of 20,038 shares traded.
Over the past week, the price has changed by +0.08%, over one month by +10.30%, over three months by -2.61% and over the past year by +7.16%.
Yes. Based on ValueRay Analyses, Vanguard FTSE 100 (XETRA:VUKE) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 77.73 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VUKE as of May 2025 is 44.98. This means that VUKE is currently overvalued and has a potential downside of 1.86%.
Vanguard FTSE 100 has no consensus analysts rating.
According to ValueRays Forecast Model, VUKE Vanguard FTSE 100 will be worth about 49.5 in May 2026. The stock is currently trading at 44.16. This means that the stock has a potential upside of +12%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49.5 | 12% |